The U.S. Food and Drug Administration's panel of independent advisers on Friday voted against the efficacy of Otsuka Pharma's ...

Potential NIH and FDA cuts could lower the number of new drugs that come to market in the next three decades, according to a ...

Experts worry the warning on vaginal estrogen menopause treatments is doing more harm than good and is not supported by science.

Texas has pledged public money to research ibogaine, hoping for FDA approval to aid veterans with PTSD and addiction.